Rising Cases Of Premature Births Driving Growth In The Market Due To Increasing Risk In Preterm Infants: Transformative Forces Shaping the Necrotizing Enterocolitis Market Landscape in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Necrotizing Enterocolitis Industry Market Size Be by 2025?
The valuation of the necrotizing enterocolitis sector has seen considerable upward movement lately, projected to expand its scale from $4.83 billion at the close of 2024 to $5.14 billion one year later, reflecting a steady compound annual growth rate of 6.5%; this earlier period's expansion can be credited to several converging factors, including the heightened incidence of necrotizing enterocolitis diagnoses, demographic increases across populations, greater disposable income on an individual basis, augmented financial support from governing bodies, and a rise in the number of infants born prematurely.

What's the Long-Term Growth Forecast for the Necrotizing Enterocolitis Market Size Through 2029?
Projections indicate robust expansion for the necrotizing enterocolitis market in the forthcoming years, with the value anticipated to reach $6.56 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.3%. This upward trajectory over the projection span is fundamentally driven by escalating healthcare expenditure, a higher frequency and broader presence of ulcerative colitis (UC), a greater burden of gastrointestinal ailments, the swelling demographic of elderly and obese individuals, and the overall augmentation of the aged population base. Key developments shaping this period involve progress in research aimed at identifying biomarkers for earlier NEC identification, the emergence of less invasive diagnostic procedures, increased utilization of sophisticated surveillance apparatus, improvements in surgical methods, and the creation of therapy approaches focusing on specific targets.

View the full report here:
https://www.thebusinessresearchcompany.com/report/necrotizing-enterocolitis-global-market-report

What Are the Key Growth Drivers Fueling the Necrotizing Enterocolitis Market Expansion?
The anticipated expansion of the necrotizing enterocolitis market is being fueled by the growing incidence of preterm deliveries. These early arrivals, defined as births occurring prior to 37 weeks of gestation instead of the standard 40-week period, are increasingly common due to various factors, including maternal health issues like diabetes, hypertension, and infections that elevate the chance of early labor, alongside lifestyle elements such as substance abuse, smoking, and inadequate dietary habits. Since premature infants possess underdeveloped digestive tracts, they are more vulnerable to inflammation and infections, resulting in an uptick in necrotizing enterocolitis (NEC) diagnoses. As an illustration, data from the US-based governmental organization, the Centers for Disease Control and Prevention, indicated in January 2024 that premature births constituted 8.67% of all births within the United States over the course of that year; consequently, the escalating volume of premature births serves as a key catalyst for the necrotizing enterocolitis market's upward trajectory.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22068&type=smp

What Are the Key Trends Driving Necrotizing Enterocolitis Market Growth?
Leading firms within the necrotizing enterocolitis sector are concentrating their efforts on engineering novel product offerings, specifically cell-free sterile biologic solutions, in response to the pressing lack of adequate therapies and the imperative to enhance prognoses for premature neonates. A cell-free sterile biologic solution represents a meticulously purified, sterile liquid medium that incorporates therapeutic bioactive components like cytokines, growth factors, and proteins, which are extracted from cultivated cells but contain no whole cellular structures, with the explicit purpose of fostering tissue repair and mitigating inflammatory responses. Highlighting a major development, in the final month of 2023, Noveome Biotherapeutics, Incorporated, an American biopharmaceutical entity, was informed by the U.S. Food and Drug Administration (FDA) that it could advance its combined Phase 1-2 clinical investigation for ST266, an innovative biologic treatment intended for premature babies afflicted with necrotizing enterocolitis (NEC). This represents a landmark achievement because ST266 is projected to constitute the initial substantial therapeutic breakthrough for NEC in more than three decades, directly tackling an essential medical requirement considering the elevated levels of severe illness and fatality associated with this condition in susceptible patient groups.

How Is the Necrotizing Enterocolitis Market Segmented?
The necrotizing enterocolitismarket covered in this report is segmented -

1) By Treatment: Total Parenteral Nutrition (TPN); Gastrointestinal Decompression; Antimicrobial Therapy; Antifungal Treatment; Paracentesis; Other Treatments
2) By Diagnosis: Laboratory Tests; Imaging Techniques
3) By Stage: Stage I (Suspected Necrotizing Enterocolitis); Stage II (Definite Necrotizing Enterocolitis); Stage III (Advanced Necrotizing Enterocolitis)
4) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-User: Hospitals; Neonatal Intensive Care Units (NICUs); Specialty Clinics

Subsegments:
1) By Total Parenteral Nutrition (TPN): Standard TPN Formulations; Customized Or Individualized TPN Solutions; Lipid Emulsions for TPN; Protein And Amino Acid Supplements In TPN; Micronutrient And Electrolyte-Enhanced TPN
2) By Gastrointestinal Decompression: Nasogastric Tube (NG Tube) Decompression; Orogastric Tube Decompression; Surgical Gastrostomy for Decompression; Non-Surgical Decompression Techniques
3) By Antimicrobial Therapy: Broad-Spectrum Antibiotics; Gram-Positive Coverage Antibiotics; Gram-Negative Coverage Antibiotics; Combination Antibiotic Therapy; Prophylactic Antibiotic Strategies For High-Risk Neonates
4) By Antifungal Treatment: Systemic Antifungal Therapy; Prophylactic Antifungal Therapy For Preterm Infants; Combination Antifungal And Antibiotic Therapy For Severe NEC
5) By Paracentesis: Diagnostic Paracentesis; Therapeutic Paracentesis; Guided Paracentesis using Ultrasound Or Radiological Techniques
6) By Other Treatments: Probiotics And Prebiotics for NEC Prevention; Surgical Interventions; Stem Cell Therapy And Regenerative Medicine Approaches; Immunomodulatory Therapies; Supportive Care

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=22068&type=smp

Which Companies Are Leading the Charge in Necrotizing Enterocolitis Market Innovation?
Major companies operating in the necrotizing enterocolitis market are Abbott Laboratories, Astellas Pharma Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Boston Children's Hospital, Hollister Incorporated, UPMC Children's Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc.

Which Regions Are Leading the Global Necrotizing Enterocolitis Market in Revenue?
North America was the largest region in the necrotizing enterocolitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the necrotizing enterocolitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22068

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.